Covered recipient · General Payments record
ROBERT B BELSHE
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$384,135.48
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $36,185.00 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $17,850.00 | 9 |
| GlaxoSmithKline, LLC. | $9,750.00 | 2 |
| Merck Sharp & Dohme Corporation | $5,585.00 | 5 |
| Acerta Pharma LLC | $3,000.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,000.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104577486 | CMS |
| GlaxoSmithKline, LLC. | $5,850.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116417642 | CMS |
| GlaxoSmithKline, LLC. | $3,900.00 | 07/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116347408 | CMS |
| Merck Sharp & Dohme LLC | $562.50 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141856528 | CMS |
| Merck Sharp & Dohme LLC | $375.00 | 03/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141667506 | CMS |
| Merck Sharp & Dohme LLC | $750.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141667504 | CMS |
| Merck Sharp & Dohme LLC | $937.50 | 05/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141667508 | CMS |
| Merck Sharp & Dohme LLC | $2,960.00 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141797241 | CMS |
| PFIZER INC. | $1,750.00 | 01/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131169816 | CMS |
| PFIZER INC. | $3,325.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131224553 | CMS |
| PFIZER INC. | $2,275.00 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131418230 | CMS |
| PFIZER INC. | $2,800.00 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131312277 | CMS |
| PFIZER INC. | $2,800.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131451016 | CMS |
| PFIZER INC. | $1,050.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1130880698 | CMS |
| PFIZER INC. | $1,225.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131229106 | CMS |
| PFIZER INC. | $875.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131229110 | CMS |
| PFIZER INC. | $1,750.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131229114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.